Last reviewed · How we verify
Placebo (matched to SUZ)
Placebo is an inert substance with no active pharmacological mechanism.
At a glance
| Generic name | Placebo (matched to SUZ) |
|---|---|
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Placebo serves as a control comparator in clinical trials to establish the efficacy of the active investigational drug (SUZ) by comparison. It contains no active pharmaceutical ingredient and produces therapeutic effects only through psychological mechanisms such as expectation and conditioning.
Approved indications
Common side effects
Key clinical trials
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy (PHASE3)
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy (PHASE3)
- Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures (PHASE4)
- Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy (PHASE3)
- Evaluation of Efficacy and Safety of Suzetrigine for Acute Pain After an Abdominoplasty (PHASE3)
- Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo (matched to SUZ) CI brief — competitive landscape report
- Placebo (matched to SUZ) updates RSS · CI watch RSS
- Vertex Pharmaceuticals Incorporated portfolio CI